U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07380828) titled 'CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)' on Jan. 15.
Brief Summary: Study aims to investigate the incidence, associations and prognostic value of CRGM and its components: chronic kidney disease, type 2 diabetes, atherosclerotic cardiovascular diseases, and non-alcoholic fatty liver disease in patients with different phenotypes and severity of clinical manifestations of CHF.
Study Start Date: Feb., 2026
Study Type: OBSERVATIONAL
Condition:
Heart Failure
Cardio-renal-metabolic Syndrome
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Russian Scientific Medical Society of Therapists
Disclaimer:...